Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

JNJ 98.20 0.00 (0.00%)
price chart
Johnson & Johnson's Key Drugs Outperforming
Based on second-quarter-to-date IMS data, we see the potential for outperformance from several of Johnson & Johnson's key U.S. drugs that in aggregate could deliver some modest upside in the second quarter, although we expect this strength to be ...
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Will Patent Cliff Concerns Impact Johnson & Johnson?
While some drugmakers might have a tough time negotiating patent cliffs, a report published by Moody's Investors Service suggests Johnson & Johnson (NYSE:JNJ) might be able to negotiate its patent cliff better than most other drug manufacturers due to ...
This Could Be Johnson & Johnson's Future
Investors in a company like Johnson & Johnson (NYSE:JNJ), which is seeing increased competition for blockbuster drugs like Zytiga and Remicade, will have to look into its pipeline to see what the future could hold.
Has Johnson & Johnson's Stock Peaked?
Johnson & Johnson's stock has come down slightly from its peak value and has been more or less stable for a while in absence of any meaningful triggers.
3 Reasons Johnson & Johnson Stock Could Rise
There are few companies these days that can truly be classified as "safe" investments, but I'd opine that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is among the elite class of companies that still fits the mold. Apparently, I'm not alone ...
5 Figures to Monitor Ahead of Johnson & Johnson's Second-Quarter Report  Motley Fool
3 Reasons Why Investors Should Keep Johnson & Johnson (JNJ) Stock
How High Could Johnson & Johnson's Dividend Go?
For retirees, income investors, and those investors with a risk-averse investing style, chances are that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is a company you've considered, or rely on in your own investment or retirement portfolio.
Is Johnson & Johnson's Future on the Fast Track?  Motley Fool
Johnson & Johnson And The Supplemental Income Approach (JNJ)  Seeking Alpha
Johnson & Johnson Has a Dirty Secret About Microbeads
Instead of moving to safe, natural alternatives, Johnson & Johnson wants to replace plastic microbeads with more plastic.
FBI Investigating Johnson & Johnson Over Morcellators
PITTSBURGH (KDKA) - The FBI is now investigating Johnson & Johnson over a device used to treat thousands of women for a common problem.
Should I Buy Johnson & Johnson? 3 Pros and 3 Cons (JNJ)
Product Mix: Johnson & Johnson essentially has two sides to its business. It sells low-price, brand-name products like band aids, soaps and other health and beauty products.